Showing results (1141-1150 of 11,327) with videos related to

Sort By:
Pageof 1,133
Thrombosis and Haemostasis|November 5, 2003
Risk factors for venous thrombosis in the black populationRaj K Patel, Elizabeth Ford, Jill Thumpston, et al.
Thrombosis and Haemostasis|November 5, 2003
Anti-oxidant ebselen delays microvascular thrombus formation in the rat cremaster muscle by inhibiting platelet P-selectin expressionNicole Lindenblatt, Wolfgang Schareck, Lorenz Belusa, et al.
Thrombosis and Haemostasis|November 5, 2003
Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humansRosemarie Reiter, Ulla Derhaschnig, Alexander Spiel, et al.
Thrombosis and Haemostasis|November 5, 2003
Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expressionWei-Jian Zhang, Peter Hufnagl, Bernd R Binder, et al.
Thrombosis and Haemostasis|November 5, 2003
Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alterationNathalie Bardin, Valérie Moal, Francine Anfosso, et al.
Thrombosis and Haemostasis|February 26, 2004
Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I: novel tumor-derived factors with a high prognostic and predictive impact in breast cancerNadia Harbeck, Ronald E Kates, Katja Gauger, et al.
Thrombosis and Haemostasis|February 26, 2004
Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis modelAna H C Guimarães, Dingeman C Rijken
Thrombosis and Haemostasis|February 26, 2004
Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathyJolanta Małyszko, Jacek S Małyszko, Tomasz Hryszko, et al.
Thrombosis and Haemostasis|February 26, 2004
Prothrombinase enhancement through quantitative and qualitative changes affecting very low density lipoprotein in complex with C-reactive proteinMichael W Dennis, Colin Downey, Nicole Brufatto, et al.
Thrombosis and Haemostasis|February 26, 2004
Platelet function in mitochondriopathy with stroke and stroke-like episodesNicole Kotzailias, Josef Finsterer, Maria Zellner, et al.
Pageof 1,133